TVM Capital bolsters MENA’s healthcare with $17m investment in Neurocare

The investment supports Neurocare’s market entry into Saudi Arabia.

TVM Capital Healthcare invested $17m in Munich-headquartered neurocare group AG (Neurocare) to improve healthcare in the Middle East and North Africa (MENA) region.

The investment supports Neurocare’s plans for international growth, including market entry into Saudi Arabia, as well as to support the development of new hardware and software innovations

ALSO READ: RSSDI and Koita Foundation launch centre for digital diabetology in India

“A special objective of the Firm is improving the healthcare infrastructure in Saudi Arabia and the wider MENA Region.” Tristan de Boysson, Managing Partner, TVM Capital Healthcare, said.

“Most mental health clinics in this region rely on traditional behavioural and drug care therapy methods, thus creating a first mover advantage for companies like Neurocare, offering innovative mental health treatments with superior clinical outcomes,” de Boysson added.

TVM’s move with Neurocare marks its ninth investment to enhance local access to quality healthcare.